维普中文期刊产品整合服务
28篇 您的检索式:作者名="WERTH VP"
    题名 作者 年代 出处 被引量
1Prevention and treat-ment of systemic glucocorticoid side effects显示文摘Moghadam-Kia S Werth VP 2010Int 1 Derrnatol2010,49,3:1
2Photosensitiviy inrheumatic diseases显示文摘WERTH VP BASHIR M ZHANG W 2004J Invest Dermatol Symp Proceedings2004,9,:1
3Pathophysiology of cutaneous lu- pus erythematosus 显示文摘Achtman JC Werth VP 2015Arthritis Res Ther2015,,17:1
4Myeophenolate mofetil for in- terstitial lung disease in dermatomyositis 显示文摘Morganroth PA Kreider ME Werth VP 2010Arthritis Care Res2010,62,10:1
5Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: physician and patient/parent global activity, manual muscle testing (MMT), health assessment questionnaire (HAQ)/ child-hood health assessment questionnaire (C-HAQ), childhood myositis assessment scale (CMAS), myositis disease activity assessment tool (MDAAT), disease activity score (DAS), short form 36 (SF-36), child health questionnaire (CHQ), physician global damage, myositis damage index (MDI), quantitativemuscle testing (QMT), myositis functional index-2 (FI-2), myositis activities profile (MAP), inclusion body myositis func- tional rating scale (IBMFRS), gutaneous dermatomyositis disease area and severity index (CDASI), gutaneous assessment tool (CAT), dermatomyositis skin severity index (DSSI), skindex, and Dermatology life quality index (DLQ显示文摘Rider LG Werth VP Huber AM 2011Arthritis Care Res (Hoboken)2011,63,11:1
6Elastic fiber-associated proteins of skin in development and photoaging显示文摘WERTH VP KALATHIL SE JAWORSKY C 0,,:1
7IL-12 completely blocks ultraviolet-induced secretion of tumor necrosis factor alpha from cultured skin fibroblasts and keratinocytes显示文摘Werth VP Bashir MM Zhang W 2003J Invest Dermatol2003,120,1:1
8Pulse intravenous cyclophosamide for treatment of autoimmune blistering disease显示文摘Werth VP 1997Arch Dermatol1997,133,2:1
9What is new in the treatment of steroid-induced osteoporosis? 显示文摘Liu RH Werth VP 2007Semin Cutan Med Surg2007,26,4:1
10Pemphigus 显示文摘Santoro FA Stoopler ET Werth VP 2013DentClin North Am2013,57,:1
11Combination antimalarials in the treatment of cutaneous dermatomyositis显示文摘Ang GC Werth VP 2005Archives of Dermatology2005,141,7:1
12Intravenously administered lecithin liposomes :a synthetic antiatherogenic lipid particle 显示文摘Williams K J Werth VP Wolff JA 1984Perspect Biol Med1984,27,:1
13Cutaneous lupus erythematosus: diagnosis and treatment 显示文摘Okon LG Werth VP 2013Best Pract Res Clin Rheumatol2013,2,3:1
14Prevention and treatment ofsystemic glucocorticoid side effects显示文摘Moghadam SK Werth VP 2010Int J Dermatol2010,49,3:1
15Update on morphea:Part Ⅱ Outcome measures and treatment显示文摘Fett N Werth VP 2011J Am Acad Dermatol2011,64,2:1
16Update on management of connective tissue panniculitides显示文摘Braunstein I Werth VP 2012Dermatol Ther2012,25,2:1
17Clinical manifestations of cutaneous lupus erythematosus显示文摘 2005Autoimmun Rev2005,4,5:1
18Mannose binding lectin (MBL) polymorphisms associated with low MBL production in patients with dermtomyositis显示文摘 Berlin JA Callen JP 2002J Invest Dermatol2002,119,6:1
19Definitions and outeome measures for bullous pemphigoid: recommenda- tions by an international panel of experts显示文摘Daniel BS Murrell DF Werth VP 2012Aus J Der- matol2012,53,1:1
20Myeophenolate mofetil for interstitial lung disease in dermatomyositis 显示文摘Morganwth PA Kreider ME Werth VP 2010Arthritis Care Res2010,62,10:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费